The worldwide prevalence of cardiometabolic diseases (CMD) is increasing, and emerging
evidence implicates the gut microbiota in this multifactorial disease development …

Doxorubicin (DOX) is a broad-spectrum and highly efficient anticancer agent, but its clinical
implication is limited by lethal cardiotoxicity. Growing evidences have shown that alterations …

Prolonged use of antibacterial mouthwash is linked to an increased risk of systemic disease.
We aimed to investigate if disturbing the oral microbiota would impact the lower gut …

Emerging evidence indicates that alteration of gut microbiota plays an important role in
chronic kidney disease (CKD)-related vascular calcification (VC). We aimed to investigate …

Background Dysbiosis during childhood impacts the configuration and maturation of the
microbiota. The immaturity of the infant microbiota is linked with the development of …

Background Throughout the surge of the COVID-19 pandemic high rate of chronic diseases
have been reported, including respiratory diseases and cardiovascular diseases. The …

BACKGROUND: Dietary acculturation, or adoption of dominant culture diet by migrant
groups, influences human health. We aimed to examine dietary acculturation and its …

ABSTRACT Introduction Chronic Obstructive Pulmonary Disease (COPD) and
cardiovascular diseases (CVD) commonly co-exist. Outcomes of people living with both …

Cardio-metabolic disease is a significant global health challenge with increasing
prevalence. Recent research underscores the disruption of gut microbial balance as a key …

Background and aims Human studies about short-chain fatty acids (SCFAs), the gut
microbiome, and Type 2 diabetes (T2DM) are limited. Here we explored the association …